BackArgenica Therapeutics Overview

Argenica Therapeutics Receivables

Argenica Therapeutics's receivables is $97K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$96530.00
↓ 77.10% YoYΔ $-324921.00 vs prior year quarter

Peer trimmed avg / median

Loading

Argenica Therapeutics Receivables History

Loading

Argenica Therapeutics vs. peers: Receivables Comparison

Loading

Argenica Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Argenica Therapeutics (AGN.AX) FAQ

As of the most recent data (June 2026), AGN.AX shows a receivables of $97K. That compares with $420K in the prior-year period — down 77.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AGN.AX's receivables is now $97K (was $420K) — a 77.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Argenica Therapeutics is outperforming or lagging.

Tracking AGN.AX's receivables over time shows whether Argenica Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $97K That compares with $420K in the prior-year period — down 77.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Argenica Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $97K) with ownership activity and broader fundamentals.

Argenica Therapeutics's receivables is $97K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.